LAG-3-IMT-L4 checkpoint inhibitor (TrueBinding)

N/A

Report date: 2025/03/20 14:49:27

Base Information

Drug NameLAG-3-IMT-L4 checkpoint inhibitor (TrueBinding)

Drug Alias NameIMT-L4-LAG-3 checkpoint inhibitor (TrueBinding)LAG-3-IMT-L4 checkpoint inhibitor (Immutics)anti LAG-3-IMT-L4 antibody (Immutics)anti LAG-3-IMT-L4 antibody (TrueBinding)IMT-L4-LAG-3 checkpoint inhibitor (Immutics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionLymphocyte activation gene 3 protein inhibitors

TargetsLymphocyte activation gene 3 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTrueBinding Inc

China Registration ClassN/A

Develop Information

Active CompaniesTrueBinding Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A